Atlas Trials

Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM

Clinical trial NCT05909826 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05909826
Sponsor
Dong-A University Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Start date
2023-07-01
Primary completion
2027-06-30
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.